Φορτώνει......
DUSP2 methylation is a candidate biomarker of outcome in head and neck cancer
BACKGROUND: Biomarkers predictive of response to chemoradiotherapy (CRT) regimens for locally advanced head and neck squamous cell carcinoma (LA-HNSCC) are urgently required to identify patients in whom this approach is likely to be effective. TP53 mutations and epidermal growth factor (EGFR) overex...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Ann Transl Med |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
AME Publishing Company
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6064804/ https://ncbi.nlm.nih.gov/pubmed/30094257 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2018.06.39 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|